| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 15, 2021 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 24,723 | $182.21 | $4,504,888.74 | -0.2% | +0.8% | -17.3% | |
| Jul 15, 2021 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | President &CEO | Sell | 24,723 | $182.21 | $4,504,888.74 | -0.2% | +0.8% | -17.3% | |
| Jul 14, 2021 | NTRA Natera, Inc. | Rabinowitz Matthew59 | Executive Chairman | Sell | 76 | $116.20 | $8,831.20 | - | -4.0% | -61.6% | |
| Jul 13, 2021 | MYGN Myriad Genetics Inc | Lanchbury Jerry S81 | Chief Scientific Officer | Sell | 93,295 | $33.64 | $3,138,273.41 | -9.1% | -5.2% | -36.7% | |
| Jul 13, 2021 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 23,590 | $183.08 | $4,318,766.80 | -0.2% | +0.5% | -19.0% | |
| Jul 13, 2021 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | President &CEO | Sell | 23,590 | $183.08 | $4,318,766.80 | -0.2% | +0.5% | -19.0% | |
| Jul 12, 2021 | TWST Twist Bioscience Corp | Leproust Emily M.77 | President &CEO | Sell | 2,000 | $125.85 | $251,703.05 | -0.2% | -18.8% | -67.4% | |
| Jul 12, 2021 | GH Guardant Health, Inc. | Meresman Stanley J75 | Director | Sell | 4,934 | $124.27 | $613,148.18 | -54.9% | -16.1% | -61.0% | |
| Jul 12, 2021 | TWST Twist Bioscience Corp | Chess Robert84 | Director | Sell | 4,000 | $125.91 | $503,647.20 | -1.0% | -18.8% | -67.4% | |
| Jul 12, 2021 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 6,916 | $121.09 | $837,474.78 | -0.5% | -6.5% | -67.8% | |
| Jul 9, 2021 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 10,000 | $72.56 | $725,606.16 | -0.6% | -11.4% | -64.8% | |
| Jul 9, 2021 | MYGN Myriad Genetics Inc | Lanchbury Jerry S81 | Chief Scientific Officer | Sell | 50,000 | $32.62 | $1,631,037.06 | -6.7% | -4.4% | -40.7% | |
| Jul 9, 2021 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 10,000 | $71.05 | $710,469.17 | -0.3% | -11.4% | -64.8% | |
| Jul 9, 2021 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | President &CEO | Sell | 16,548 | $182.59 | $3,021,425.16 | -0.1% | +5.0% | -14.8% | |
| Jul 9, 2021 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 16,548 | $182.59 | $3,021,425.16 | -0.1% | +5.0% | -14.8% | |
| Jul 8, 2021 | CDNA Caredx, Inc. | Seeto Reginald76 | See Remarks | Sell | 5,994 | $85.67 | $513,503.31 | -1.5% | -26.7% | -69.7% | |
| Jul 8, 2021 | PSNL Personalis, Inc. | West John Stephen91 | President And CEO | Sell | 110,000 | $22.54 | $2,479,400.00 | -14.8% | -20.9% | -82.3% | |
| Jul 8, 2021 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 20,000 | $69.78 | $1,395,613.56 | -0.5% | -9.8% | -63.6% | |
| Jul 8, 2021 | NTRA Natera, Inc. | Schueren Robert Alan66 | Chief Operating Officer | Sell | 2,032 | $113.34 | $230,302.41 | -7.5% | -5.4% | -65.5% | |
| Jul 7, 2021 | MYGN Myriad Genetics Inc | Lanchbury Jerry S81 | Chief Scientific Officer | Sell | 32,308 | $32.27 | $1,042,660.12 | -6.5% | -1.6% | -38.8% | |
| Jul 7, 2021 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | President &CEO | Sell | 9,303 | $180.46 | $1,678,792.24 | - | +8.4% | -11.4% | |
| Jul 7, 2021 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 9,303 | $180.46 | $1,678,792.24 | - | +8.4% | -11.4% | |
| Jul 7, 2021 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 32,465 | $117.18 | $3,804,301.21 | -4.6% | -4.7% | -65.4% | |
| Jul 6, 2021 | RVTY Revvity, Inc. | Gregoire Sylvie | Director | Sell | 5,000 | $155.57 | $777,850.00 | -22.3% | +9.7% | -6.3% | |
| Jul 6, 2021 | CDNA Caredx, Inc. | Maag Peter83 | Executive Chair | Sell | 10,000 | $90.70 | $907,002.19 | -0.9% | -30.1% | -72.4% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.